Facilitation of GluN2C-containing NMDA receptors in the external globus pallidus increases firing of fast spiking neurons and improves motor function in a hemiparkinsonian mouse model

NEUROBIOLOGY OF DISEASE

卷:150

Article

Liu, Jinxu¹  Shelkar, Gajanan P.¹  Sarode, Lopmudra P.²  Gawande, Dinesh Y.¹  Zhao, Fabao³  Clausen, Rasmus Praetorius³  Ugale, Rajesh R.²  Dravid, Shashank Manohar¹ 

[1] Creighton Univ, Dept Pharmacol & Neurosci, Sch Med, 2500 Calif Plaza, Omaha, NE 68178 USA

[2] Rashtrasant Tukadoji Maharaj Nagpur Univ, Dept Pharmaceut Sci, Nagpur 440033, Maharashtra, India

[3] Univ Copenhagen, Fac Hlth & Med Sci, Dept Drug Design & Pharmacol, Univ Pk 2, DK-2100 Copenhagen, Denmark

关键词: NMDA;    GluN2C;    GRIN2C;    Parkinson's disease;    Parvalbumin;    Oscillations;   

DOI  :  10.1016/j.nbd.2021.105254

来源: Elsevier

【 摘 要 】

Globus pallidus externa (GPe) is a nucleus in the basal ganglia circuitry involved in the control of movement. Recent studies have demonstrated a critical role of GPe cell types in Parkinsonism. Specifically increasing the function of parvalbumin (PV) neurons in the GPe has been found to facilitate motor function in a mouse model of Parkinson's disease (PD). The knowledge of contribution of NMDA receptors to GPe function is limited. Here, we demonstrate that fast spiking neurons in the GPe express NMDA receptor currents sensitive to GluN2C/GluN2D-selective inhibitors and glycine site agonist with higher efficacy at GluN2C-containing receptors. Furthermore, using a novel reporter model, we demonstrate the expression of GluN2C subunits in PV neurons in the GPe which project to subthalamic nuclei. GluN2D subunit was also found to localize to PV neurons in GPe. Ablation of GluN2C subunit does not affect spontaneous firing of fast spiking neurons. In contrast, facilitating the function of GluN2C-containing receptors using glycine-site NMDA receptor agonists, D-cycloserine (DCS) or AICP, increased the spontaneous firing frequency of PV neurons in a GluN2C-dependent manner. Finally, we demonstrate that local infusion of DCS or AICP into the GPe improved motor function in a mouse model of PD. Together, these results demonstrate that GluN2C-containing receptors and potentially GluN2D-containing receptors in the GPe may serve as a therapeutic target for alleviating motor dysfunction in PD and related disorders.